COMPARISON OF EQUILIBRIUM TIMES IN DIALYSIS EXPERIMENTS USING SPIKED PLASMA OR SPIKED BUFFEROIE S; GUENTERT TW.1982; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 1; PP. 127-128; BIBL. 1 REF.Article

FACTORS INFLUENCING THE APPARENT PROTEIN BINDING OF QUINIDINEGUENTERT TW; OIE S.1982; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 3; PP. 325-328; BIBL. 20 REF.Article

EFFECT OF PLASMA PROTEIN BINDING ON QUINIDINE KINETICS IN THE RABBITGUENTERT TW; OIE S.1980; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1980; VOL. 215; NO 1; PP. 165-171; BIBL. 38 REF.Article

EFFECT OF SATURABLE BINDING ON THE PHARMACOKINETICS OF DRUGS: A SIMULATIONOIE S; GUENTERT TW; TOZER TN et al.1980; J. PHARM. PHARMACOL.; GBR; DA. 1980; VOL. 32; NO 7; PP. 471-477; BIBL. 25 REF.Article

ISOLATION, CHARACTERISATION AND SYNTHESIS OF A NEW QUINIDINE METABOLITEGUENTERT TW; DALY JJ; RIEGELMAN S et al.1982; EUR. J. DRUG METAB. PHARMACOKINET.; ISSN 0378-7966; CHE; DA. 1982; VOL. 7; NO 1; PP. 31-38; BIBL. 30 REF.Article

CONVENIENT AND SENSITIVE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY ASSAY FOR KETOPROFEN, NAPROXEN AND OTHER ALLIED DRUGS IN PLASMA OR URINEUPTON RA; BUSKIN JN; GUENTERT TW et al.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 190; NO 1; PP. 119-128; BIBL. 13 REF.Article

QUINIDINE PHARMACOKINETICS IN MAN: CHOICE OF A DISPOSITION MODEL AND ABSOLUTE BIOAVAILABILITY STUDIESGUENTERT TW; HOLFORD NHG; COATES PE et al.1979; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1979; VOL. 7; NO 4; PP. 315-330; BIBL. 26 REF.Article

KETOPROFEN PHARMACOKINETICS AND BIOAVAILABILITY BASED ON AN IMPROVED SENSITIVE AND SPECIFIC ASSAYUPTON RA; WILLIAMS RL; GUENTERT TW et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 2; PP. 127-133; BIBL. 28 REF.Article

DIVERGENCE IN PHARMACOKINETIC PARAMETERS OF QUINIDINE OBTAINED BY SPECIFIC ASSAY METHODSGUENTERT TW; UPTON RA; HOLFORD NHG et al.1979; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1979; VOL. 7; NO 3; PP. 303-311; BIBL. 29 REF.Article

GASTROINTESTINAL ABSORPTION OF QUINIDINE FROM SOME SOLUTIONS AND COMMERCIAL TABLETSGUENTERT TW; UPTON RA; HOLFORD NHG et al.1980; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1980; VOL. 8; NO 3; PP. 243-255; BIBL. 18 REF.Article

DETERMINATION OF QUINIDINE AND METABOLITES IN URINE BY REVERSE-PHASE HIGH-PRESSURE LIQUID CHROMATOGRAPHYBONORA MR; GUENTERT TW; UPTON RA et al.1979; CLIN. CHIM. ACTA; NLD; DA. 1979; VOL. 91; NO 3; PP. 277-284; BIBL. 24 REF.Article

THE EFFECT OF QUINIDINE AND ITS METABOLITES ON THE ELECTROCARDIOGRAM AND SYSTOLIC TIME INTERVALS: CONCENTRATION-EFFECT RELATIONSHIPSHOLFORD NHG; COATES PE; GUENTERT TW et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 2; PP. 187-195; BIBL. 42 REF.Article

DETERMINATION OF QUINIDINE AND ITS MAJOR METABOLITES BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYGUENTERT TW; COATES PE; UPTON RA et al.1979; J. CHROMATOGRAPHY; NLD; DA. 1979; VOL. 162; NO 1; PP. 59-70; BIBL. 46 REF.Article

EVALUATION OF A MODIFIED HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY ASSAY FOR ACEBUTOLOL AND ITS MAJOR METABOLITEGUENTERT TW; WIENTJES GM; UPTON RA et al.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 163; NO 4; PP. 373-382; BIBL. 6 REF.Article

AN INTEGRATED APPROACH TO MEASUREMENTS OF QUINIDINE AND METABOLITES IN BIOLOGICAL FLUIDSGUENTERT TW; RAKHIT A; UPTON RA et al.1980; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1980; VOL. 183; NO 4; PP. 514-518; BIBL. 13 REF.Article

INTRAINDIVIDUAL VARIABILITY IN THEOPHYLLINE PHARMACOKINETICS: STATISTICAL VERIFICATION IN 39 OF 60 HEALTHY YOUNG ADULTSUPTON RA; THIERCELIN JF; GUENTERT TW et al.1982; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1982; VOL. 10; NO 2; PP. 123-134; BIBL. 23 REF.Article

EVALUATION OF THE ABSORPTION FROM SOME COMMERCIAL ENTERIC-RELEASE THEOPHYLLINE PRODUCTSUPTON RA; POWELL JR; GUENTERT TW et al.1980; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1980; VOL. 8; NO 2; PP. 151-164; BIBL. 17 REF.Article

PARTIALSYNTHETISCHE VERSUCHE IN DER REIHE DER HERZGIFTE. XII: DIE SYNTHESE VON 3BETA -ACETOXY-24-AZA-24-DESOXA-XYSMALOGENIN = SYNTHESES PARTIELLES DANS LA SERIE DES POISONS DU COEUR. XII: SYNTHESE D'ACETOXY-3BETA AZA-24 DESOXA-24 XYSMALOGENINEEL DINE S; FAUST K; GUENTERT TW et al.1979; HELV. CHIM. ACTA; CHE; DA. 1979; VOL. 62; NO 4; PP. 1283-1287; BIBL. 9 REF.Article

EVALUATION OF THE ABSORPTION FROM 15 COMMERCIAL THEOPHYLLINE PRODUCTS INDICATING DEFICIENCIES IN CURRENTLY APPLIED BIOAVAILABILITY CRITERIAUPTON RA; SANSOM L; GUENTERT TW et al.1980; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1980; VOL. 8; NO 3; PP. 229-242; BIBL. 27 REF.Article

EVALUATION OF THE ABSORPTION FROM SOME COMMERCIAL SUSTAINED-RELEASE THEOPHYLLINE PRODUCTSUPTON RA; THIERCELIN JF; GUENTERT TW et al.1980; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1980; VOL. 8; NO 2; PP. 131-149; BIBL. 26 REF.Article